115 related articles for article (PubMed ID: 3843840)
21. Isolation of a cationic fragment of high molecular mass kininogen and effect of this fragment on human plasma kallikrein activity.
Yarovaya GA; Dotsenko VL; Orekhovich VN
Clin Chim Acta; 1982 Aug; 123(3):261-7. PubMed ID: 6922013
[TBL] [Abstract][Full Text] [Related]
22. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
Meier HL; Pierce JV; Colman RW; Kaplan AP
J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
[TBL] [Abstract][Full Text] [Related]
23. Plasma prekallikrein: isolation, characterization, and mechanism of activation.
Wuepper KD; Cochrane CG
J Exp Med; 1972 Jan; 135(1):1-20. PubMed ID: 4536682
[TBL] [Abstract][Full Text] [Related]
24. Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma.
Kerbiriou DM; Griffin JH
J Biol Chem; 1979 Dec; 254(23):12020-7. PubMed ID: 500690
[TBL] [Abstract][Full Text] [Related]
25. Rapid purification of a prekallikrein from rat pancreas.
Matsas R; Proud D; Nustad K; Bailey GS
Anal Biochem; 1981 May; 113(2):264-70. PubMed ID: 6912775
[No Abstract] [Full Text] [Related]
26. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
[TBL] [Abstract][Full Text] [Related]
27. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.
Schapira M; Scott CF; Colman RW
Biochemistry; 1981 May; 20(10):2738-43. PubMed ID: 6910423
[TBL] [Abstract][Full Text] [Related]
28. Isolation and functional properties of the heavy and light chains of human plasma kallikrein.
van der Graaf F; Tans G; Bouma BN; Griffin JH
J Biol Chem; 1982 Dec; 257(23):14300-5. PubMed ID: 6815193
[TBL] [Abstract][Full Text] [Related]
29. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
Ratnoff OD; Saito H
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
[TBL] [Abstract][Full Text] [Related]
30. Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin.
Heck LW; Kaplan AP
J Exp Med; 1974 Dec; 140(6):1615-30. PubMed ID: 4547783
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of prokallikreins and kallikreins from rat pancreatic tissue and juice.
Jaffa AA; Hussain M; Rashid Z; Bailey GS
Adv Exp Med Biol; 1986; 198 Pt A():323-7. PubMed ID: 3643715
[TBL] [Abstract][Full Text] [Related]
32. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin.
Espana F; Aznar J; Estelles A
J Lab Clin Med; 1982 Nov; 100(5):756-70. PubMed ID: 6182261
[TBL] [Abstract][Full Text] [Related]
33. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins.
Colman RW; Mattler L; Sherry S
J Clin Invest; 1969 Jan; 48(1):11-22. PubMed ID: 4974623
[TBL] [Abstract][Full Text] [Related]
34. Effect of kininogen on the activity of the kallikreinogen-kallikrein system of human blood serum.
Yarovaya GA; Dotsenko VL; Orekhovich VN
Clin Chim Acta; 1977 Jul; 78(1):85-9. PubMed ID: 884851
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
Griffin JH; Cochrane CG
Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
[TBL] [Abstract][Full Text] [Related]
36. Purification and characterization of rat plasma kallikrein.
Bedi GS; Back N
Prep Biochem; 1984 Aug; 14(3):257-79. PubMed ID: 6567197
[TBL] [Abstract][Full Text] [Related]
37. Protein-protein interactions in contact activation of blood coagulation. Characterization of fluorescein-labeled human high molecular weight kininogen-light chain as a probe.
Bock PE; Shore JD
J Biol Chem; 1983 Dec; 258(24):15079-86. PubMed ID: 6558074
[TBL] [Abstract][Full Text] [Related]
38. Purification of human serum prekallikrein, some properties of the purified proenzyme and its stability.
Kawiak J; Kawalec M; Dotsenko VL; Yarovaya GA
Clin Chim Acta; 1984 Aug; 141(2-3):287-92. PubMed ID: 6567485
[No Abstract] [Full Text] [Related]
39. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.
Mandle RJ; Colman RW; Kaplan AP
Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4179-83. PubMed ID: 1069308
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of human prekallikrein deficiency (Fletcher trait): evidence that five of 18 cases are positive for cross-reacting material.
Saito H; Goodnough LT; Soria J; Soria C; Aznar J; España F
N Engl J Med; 1981 Oct; 305(16):910-4. PubMed ID: 6792540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
